The Economic Impact of Lung Disease
Lung disease has a deep impact in Canada. Lung cancer remains the leading cause of death from cancer for both genders and each year more people die of lung cancer than those of prostate cancer, breast cancer, and colorectal cancer combined.
According to the Canadian Lung Association, the three leading lung diseases — asthma, COPD, and lung cancer — cost the Canadian economy a staggering $12 billion in 2010. More than 6 percent of Canada’s welfare bill is taken up by chronic lung disease care.
When it comes to hospitalizations, those with COPD outnumber all other patients. It’s estimated that a large number of Canadians have COPD or asthma but have not yet been diagnosed. Experts predict that the bill for caring for patients with chronic lung disease in Canada will have doubled by 2030 if drastic steps aren’t taken to help improve Canadians’ lung health.
Measures have been put in place to reduce smoking and secondhand smoke, as well as improve both indoor and outdoor air quality. These steps will hopefully help prevent additional cases of COPD, asthma and lung cancer and reduce the economic burden of these and other chronic lung diseases.
Pulmonary Fibrosis News is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or another qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.